Equity Vaccines Ltd. is excited to announce that we are preparing for the next major milestone in the development of our groundbreaking Equivac Malaria Vaccine—clinical trials! After completing rigorous preclinical testing, we are now getting ready to launch human trials that will bring us one step closer to delivering a life-saving solution to millions at risk of malaria.
What to Expect
Equity Health Group is striving to become a leading healthcare provider in Nigeria, committed to delivering innovative, patient-centered medical services across the country and beyond. Through its subsidiaries, including Equity Specialist Clinics & Diagnostic Centre, Equity Vaccines, Equity Pharmaceuticals, and Equity Telemedicine Solutions, the group aims to revolutionize healthcare delivery and improve the well-being of all Nigerians.
Stay Tuned For Update
While the trials have not yet begun, we invite you to follow our progress and receive updates on this exciting journey.
